Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
36.77
-1.54 (-4.02%)
May 15, 2026, 4:00 PM EDT - Market closed
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $3.88 billion as of May 15, 2026. Its market cap has increased by 23.53% in one year.
Market Cap
3.88B
Enterprise Value
2.63B
1-Year Change
23.53%
Ranking
Category
Stock Price
$36.77
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $3.88B, an increase of 587.51%. That is a compound annual growth rate of 27.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 3.88B | -12.23% |
| Dec 31, 2025 | 4.42B | -6.84% |
| Dec 31, 2024 | 4.74B | 99.51% |
| Dec 29, 2023 | 2.38B | 141.36% |
| Dec 30, 2022 | 984.73M | -26.50% |
| Dec 31, 2021 | 1.34B | 188.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 4.30B |
| Caris Life Sciences | 4.13B |
| Veradermics | 4.09B |
| NewAmsterdam Pharma Company | 4.06B |
| Travere Therapeutics | 3.98B |
| Catalyst Pharmaceuticals | 3.81B |
| Oruka Therapeutics | 3.70B |
| ACADIA Pharmaceuticals | 3.70B |